Similar articles for PMID: 32887766

Year	Number of Results
1999	1
2003	1
2004	1
2005	2
2006	1
2007	4
2008	5
2009	5
2010	2
2011	5
2012	6
2013	10
2014	9
2015	8
2016	10
2017	11
2018	9
2019	9
2020	6
2021	1

1

Letter to editor re "Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential 18F-FDG-PET Exams".

Birnie D. Birnie D. J Nucl Med Technol. 2020 Sep 4:jnmt.120.254276. doi: 10.2967/jnmt.120.254276. Online ahead of print. J Nucl Med Technol. 2020. PMID: 32887766 No abstract available.

2

Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential ¹⁸F-FDG PET Examinations.

Ostwani W, Hanna C, Brice AE, Wymer DC. Ostwani W, et al. J Nucl Med Technol. 2020 Dec;48(4):378-380. doi: 10.2967/jnmt.120.246322. Epub 2020 Jun 9. J Nucl Med Technol. 2020. PMID: 32518122 Review.

3

Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.

Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, Miura M, Sakaue S, Tamaki N, Nishimura M. Ohira H, et al. Eur J Nucl Med Mol Imaging. 2008 May;35(5):933-41. doi: 10.1007/s00259-007-0650-8. Epub 2007 Dec 15. Eur J Nucl Med Mol Imaging. 2008. PMID: 18084757

4

Quantitative interpretation of FDG PET for cardiac sarcoidosis reclassifies visually interpreted exams and potentially impacts downstream interventions.

Merilyn V, Dia S, Lavanya B, Lynda ER, Barry Z, Edward JM. Merilyn V, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(4):342-353. doi: 10.36141/svdld.v35i4.7342. Epub 2020 Mar 9. Sarcoidosis Vasc Diffuse Lung Dis. 2018. PMID: 32476922 Free PMC article.

5

Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.

Zandieh S, Bernt R, Mirzaei S, Haller J, Hergan K. Zandieh S, et al. J Nucl Cardiol. 2018 Aug;25(4):1128-1134. doi: 10.1007/s12350-016-0653-6. Epub 2016 Sep 7. J Nucl Cardiol. 2018. PMID: 27604109

6

Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.

Nishiyama Y, Yamamoto Y, Fukunaga K, Takinami H, Iwado Y, Satoh K, Ohkawa M. Nishiyama Y, et al. J Nucl Med. 2006 Oct;47(10):1571-6. J Nucl Med. 2006. PMID: 17015889 Free article.

7

Diagnostic Performance of <sup>18</sup>F-FDG PET/CT Semiquantitative Analysis in the Management of Sarcoidosis.

Rubini G, Ferrari C, Altini C, Cimino A, Fanelli M, Niccoli Asabella A. Rubini G, et al. Curr Med Imaging Rev. 2019;15(1):32-38. doi: 10.2174/1573405614666180522075828. Curr Med Imaging Rev. 2019. PMID: 31964325

8

18F-FDG PET as a predictor of pulmonary function in sarcoidosis.

Keijsers RG, Verzijlbergen EJ, van den Bosch JM, Zanen P, van de Garde EM, Oyen WJ, Grutters JC. Keijsers RG, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):123-9. Sarcoidosis Vasc Diffuse Lung Dis. 2011. PMID: 22117503

9

Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M. Okumura W, et al. J Nucl Med. 2004 Dec;45(12):1989-98. J Nucl Med. 2004. PMID: 15585472 Free article.

10

Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis.

Sobic-Saranovic DP, Grozdic IT, Videnovic-Ivanov J, Vucinic-Mihailovic V, Artiko VM, Saranovic DZ, Pavlovic SV, Obradovic VB. Sobic-Saranovic DP, et al. Clin Nucl Med. 2013 Jul;38(7):516-21. doi: 10.1097/RLU.0b013e31828731f5. Clin Nucl Med. 2013. PMID: 23486337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed